aetiology
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
10.12.2019
Asclepion Laser Technologies: Steady growth enables investment in the future
On September 9, an extension to the main building of Asclepion Laser Technologies GmbH was inaugurated and the usable floor space almost doubled by a further 2,500 m2 during a […]
12.05.2016
BASF receives halal certification for personal and home care ingredients
Düsseldorf, Germany– BASF now offers 145 ingredients for personal and home care products which have been certified to the international halal standard HAS 23000: Along the entire value chain, strict […]